Prostate implant
Showing 1 - 25 of 9,444
Prostate Cancer Trial in Québec (Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant, Stereotactic Body
Recruiting
- Prostate Cancer
- Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant
- Stereotactic Body Radiation Therapy to the prostate
-
Québec, CanadaCentre Intégré de Cancérologie, CHU de Québec-Université Laval
Sep 21, 2023
Prostate Cancer Trial in Grenoble (Interstitial Brachytherapy of the Prostate With Iodine 125 Implant With Target Dose
Not yet recruiting
- Prostate Cancer
- Interstitial Brachytherapy of the Prostate With Iodine 125 Implant With Target Dose Supplementation in the Tumor Volume Guided by the TRINITY® PERINE 3D
-
Grenoble, FranceIsabelle Boudry
Apr 1, 2022
Prostate Cancer Trial in Guangzhou (Goserelin Acetate Sustained-Release Microspheres for Injection, Zoladex 10.8 MG Drug
Not yet recruiting
- Prostate Cancer
- Goserelin Acetate Sustained-Release Microspheres for Injection
- Zoladex 10.8 MG Drug Implant
-
Guangzhou, ChinaSun Yat-sen Memorial Hospital of Sun Yat-sen University
May 3, 2023
BioProtect Balloon Implant System
Recruiting
- Prostate Cancer
-
Petah Tikva, Israel
- +1 more
May 16, 2022
Prostate Cancer Trial in Leeds (Radical Prostatectomy, Brachytherapy)
Terminated
- Prostate Cancer
- Radical Prostatectomy
- Brachytherapy
-
Leeds, England, United KingdomLeeds Cancer Centre at St. James's University Hospital
Dec 16, 2021
Oligometastatic Prostate Cancer Trial in Canada (Hypofractionated external beam radiotherapy, High dose rate brachytherapy,
Recruiting
- Oligometastatic Prostate Cancer
- Hypofractionated external beam radiotherapy
- +3 more
-
Kelowna, British Columbia, Canada
- +3 more
Mar 3, 2022
Prostate Cancer Trial in New York (device, procedure, radiation)
Recruiting
- Prostate Cancer
- Medical Device Usage and Evaluation
- +4 more
-
New York, New YorkMount Sinai Hospital
Jan 25, 2022
Prostate Cancer Trial in Guangzhou (LY01005, ZOLADEX® 3.6 mg)
Active, not recruiting
- Prostate Cancer
- LY01005
- ZOLADEX® 3.6 mg
-
Guangzhou, ChinaSun Yat-sen Memorial Hospital of Sun Yat-sen University
Nov 19, 2021
Prostate Cancer Trial in Shanghai (LY01005 3.6 mg, ZOLADEX® 3.6 mg)
Completed
- Prostate Cancer
- LY01005 3.6 mg
- ZOLADEX® 3.6 mg
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 20, 2021
Prostate Cancer Trial in Québec (Permanent Iodine-125 seed implant, High-Dose-rate Prostate Brachytherapy)
Completed
- Prostate Cancer
- Permanent Iodine-125 seed implant
- High-Dose-rate Prostate Brachytherapy
-
Québec, Quebec, CanadaCHU de Québec- L'Hôtel-Dieu de Québec
Feb 8, 2021
Patients After 3-months of Leuprorelin 5mg Implant in Prostate
Not yet recruiting
- Prostate Cancer
- Leuprolide Acetate
- (no location specified)
Sep 30, 2020
Prostate Adenocarcinoma, Lower Urinary Tract Symptoms Trial in Australia, New Zealand (Bicalutamide implant)
Unknown status
- Prostate Adenocarcinoma
- Lower Urinary Tract Symptoms
- Bicalutamide implant
-
Wahroonga, New South Wales, Australia
- +3 more
Jan 13, 2021
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial (brachytherapy, image-guided radiation
Withdrawn
- Adenocarcinoma of the Prostate
- +4 more
- brachytherapy
- +2 more
- (no location specified)
Jul 23, 2020
Prostate Cancer Trial in Canada, Georgia (Goserelin Acetate)
Completed
- Prostate Cancer
- Goserelin Acetate
-
Abbotsford, British Columbia, Canada
- +6 more
May 6, 2021
Prostate Cancer Trial in Kelowna (Low dose rate prostate brachytherapy, High dose rate prostate brachytherapy)
Recruiting
- Prostate Cancer
- Low dose rate prostate brachytherapy
- High dose rate prostate brachytherapy
-
Kelowna, British Columbia, CanadaBritish Columbia Cancer Agency Center for the Southern Interior
Oct 15, 2020
BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms Trial in Wahroonga, Tauranga (RT-310)
Not yet recruiting
- BPH (Benign Prostatic Hyperplasia)
- Lower Urinary Tract Symptoms
- RT-310
-
Wahroonga, New South Wales, Australia
- +1 more
Nov 13, 2023
Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia Trial in Tbilisi (Omega device)
Recruiting
- Lower Urinary Tract Symptoms
- Benign Prostatic Hyperplasia
- Omega device
-
Tbilisi, Georgia
- +1 more
Mar 8, 2023
Prostate Cancer Trial in Greenfield Park (HDR brachytherapy as monotherapy)
Completed
- Prostate Cancer
- HDR brachytherapy as monotherapy
-
Greenfield Park, Quebec, CanadaHôpital Charles LeMoyne
Mar 15, 2022
Prostate Cancer Trial (Urolift, SABR)
Not yet recruiting
- Prostate Cancer
- Urolift
- SABR
- (no location specified)
Jun 23, 2022
Prostate Cancer Trial in Houston (Brachytherapy, Questionnaire)
Active, not recruiting
- Prostate Cancer
- Brachytherapy
- Questionnaire
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 23, 2021
A Multi-centre, Prospective, Observational Study on
Completed
- Localized or Locally Advanced Prostate Cancer
-
Beijing, Beijing, China
- +22 more
Mar 5, 2020
US-CT Fusion for Post Implant Dosimetry
Completed
- Prostate Cancer
- transrectal ultrasound
-
Kelowna, British Columbia, CanadaBC Cancer
Jan 23, 2020
Prostate Cancer Trial in London, Carlisle (TURP, UroLift)
Recruiting
- Prostate Cancer
- TURP
- UroLift
-
London, Lon, United Kingdom
- +2 more
Apr 24, 2023